M-5542

N/A

Report date: 2026/02/05 20:00:17

Base Information

Drug NameM-5542

Drug Alias NameM5542M-5542

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCluster of differentiation 80 inhibitorsCluster of differentiation 86 inhibitorsTumor necrosis factor ligand superfamily member 4 inhibitors

TargetsCluster of differentiation 80Cluster of differentiation 86Tumor necrosis factor ligand superfamily member 4

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesMerck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A